Fluetonitazene

Fluetonitazene
Identifiers
	IUPAC name N,N-diethyl-2-[2-[[4-(2-fluoroethoxy)phenyl]methyl]-5-nitrobenzimidazol-1-yl]ethanamine;
PubChem CID	172332078;
Chemical and physical data
Formula	C22H27FN4O3
Molar mass	414.481 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCCF;
	InChI InChI=1S/C22H27FN4O3/c1-3-25(4-2)12-13-26-21-10-7-18(27(28)29)16-20(21)24-22(26)15-17-5-8-19(9-6-17)30-14-11-23/h5-10,16H,3-4,11-15H2,1-2H3; Key:XCWWXPKOMYPTRP-UHFFFAOYSA-N;

Fluetonitazene (fluornitrazene, F-etonitazene, 2-fluoroetonitazene) is a benzimidazole derivative which is an opioid designer drug. It was patented in 2024 as a potential novel analgesic,^[1] but appeared on the illicit market at around the same time, first being identified in Germany in March 2024.^[2]^[3] It is a potent opioid agonist in vitro with similar potency to N-Desethyletonitazene.^[4]

PubChem CID

172332078

FormulaC₂₂H₂₇FN₄O₃

Molar mass414.481 g·mol⁻¹

3D model (JSmol)

Interactive image

Quick facts Identifiers, PubChem CID ...

Close

[1]

[2]

[3]

[4]

Fluetonitazene

See also

References

Related Articles

Identifiers

IUPAC name N,N-diethyl-2-[2-[[4-(2-fluoroethoxy)phenyl]methyl]-5-nitrobenzimidazol-1-yl]ethanamine
PubChem CID	172332078
Chemical and physical data
Formula	C₂₂H₂₇FN₄O₃
Molar mass	414.481 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCN(CC)CCN1C2=C(C=C(C=C2)[N+](=O)[O-])N=C1CC3=CC=C(C=C3)OCCF
InChI InChI=1S/C22H27FN4O3/c1-3-25(4-2)12-13-26-21-10-7-18(27(28)29)16-20(21)24-22(26)15-17-5-8-19(9-6-17)30-14-11-23/h5-10,16H,3-4,11-15H2,1-2H3 Key:XCWWXPKOMYPTRP-UHFFFAOYSA-N